Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AUSL 8 (Azienda Unità Sanitaria Locale n. 8) is a public healthcare authority in Italy, currently primarily represented by the ASL 8 of Cagliari in Sardinia. Historically, the name also referred to the health authorities of Arezzo and Siracusa before regional reorganizations. As a public health entity, AUSL 8 is responsible for managing hospitals, clinics, and health services for its local population. It is a significant participant in the life sciences sector as a clinical trial site and occasional sponsor of independent clinical research, collaborating with major pharmaceutical companies such as AbbVie, Bayer, and Novartis. The organization provides comprehensive medical care across various specialties, including cardiology, oncology, and emergency medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AUSL 8.